McDermott Will & Emery, with a string of large healthcare M&A and litigation matters in 2023, saw its gross revenue climb 5.8% to $1.92 billion and its profits per equity partner shoot up nearly 13%.
Amid a 2% drop in its equity tier, the firm’s net income for equity partners grew 10.5%. The firm’s profit per equity in 2023, $3.76 million, was a new high for the firm. For context, its PEP in 2018 was $1.88 million, or about half that.
